AFP and liver cancer: Additional analysis with Wilcoxon's test confirmed that AFP-positive liver cancer cells (average rank: 38.50) were significantly more sensitive to gemcitabine than AFP-negative cells (average rank: 25.79) (W = 490.000, Z = −2.567, P=0.010).